NextCell publishes its Interim Report 3 2023/2024
NextCell Pharma AB (publ) (NXTCL or NextCell) publishes its Interim Report 3 for the period September 1, 2023 – May 31, 2024. The report is available on the company’s website: https://www.nextcellpharma.com/en/investors#financial-report. NextCells share is traded on Nasdaq First North Growth Market under the ticker "NXTCL". The amount in brackets refers to the corresponding period in the previous year.Third quarter (2024-03-01 until 2024-05-31) ● Operating income amounted to 2,482 (4,189) TSEK, of which Cellaviva amounted to 2,442 (3,040) TSEK. ● Net Income amounted to 2,442 (3,